Detalhe da pesquisa
1.
Clinically meaningful improvement in symptoms and quality of life for patients with non-small-cell lung cancer receiving gefitinib in a randomized controlled trial.
J Clin Oncol
; 23(13): 2946-54, 2005 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-15699477
2.
TRIBUTE: a phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer.
J Clin Oncol
; 23(25): 5892-9, 2005 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16043829
3.
Efficacy of gefitinib, an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial.
JAMA
; 290(16): 2149-58, 2003 Oct 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-14570950
4.
A phase 2 randomized trial of paclitaxel and carboplatin with or without panitumumab for first-line treatment of advanced non-small-cell lung cancer.
J Thorac Oncol
; 8(12): 1510-8, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24389433
5.
Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia.
J Clin Oncol
; 29(1): 97-105, 2011 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21098317
6.
Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.
J Clin Oncol
; 25(27): 4270-7, 2007 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17878479
7.
Randomized phase II trial of pemetrexed combined with either cisplatin or carboplatin in untreated extensive-stage small-cell lung cancer.
J Clin Oncol
; 24(30): 4840-7, 2006 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-17050869
8.
Phase II trial of irinotecan in combination with amifostine in patients with advanced colorectal carcinoma.
Cancer
; 94(8): 2174-9, 2002 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12001114